Works matching IS 00099236 AND DT 2018 AND VI 104 AND IP 3
Results: 24
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 418, doi. 10.1002/cpt.1173
- Publication type:
- Article
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 409, doi. 10.1002/cpt.1170
- Publication type:
- Article
Highlights.
- Published in:
- 2018
- Publication type:
- Abstract
“Green Medicine”: The Past, Present, and Future of Botanicals.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 410, doi. 10.1002/cpt.1168
- By:
- Publication type:
- Article
Cinnamon and Cassia Nomenclature Confusion: A Challenge to the Applicability of Clinical Data.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 435, doi. 10.1002/cpt.1162
- By:
- Publication type:
- Article
A Tiered Approach for the Evaluation of the Safety of Botanicals Used as Dietary Supplements: An Industry Strategy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 446, doi. 10.1002/cpt.1132
- By:
- Publication type:
- Article
Getting to the Root of the Matter: Challenges and Recommendations for Assessing the Safety of Botanical Dietary Supplements.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 429, doi. 10.1002/cpt.1088
- By:
- Publication type:
- Article
Industry Actions to Address Quality Issues for Dietary Supplements, Botanicals, and Other Natural Products.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 423, doi. 10.1002/cpt.1119
- By:
- Publication type:
- Article
Challenges and Opportunities for Improving the Safety Assessment of Botanical Dietary Supplements: A United States Pharmacopeia Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 426, doi. 10.1002/cpt.1113
- By:
- Publication type:
- Article
Safety Surveillance of Dietary Supplements: Importance, Challenges, and New Horizons.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 432, doi. 10.1002/cpt.1101
- By:
- Publication type:
- Article
Botanicals and Hepatotoxicity.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 458, doi. 10.1002/cpt.1097
- By:
- Publication type:
- Article
“…Not Intended to Diagnose, Treat, Cure or Prevent Any Disease.” 25 Years of Botanical Dietary Supplement Research and the Lessons Learned.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 470, doi. 10.1002/cpt.1131
- By:
- Publication type:
- Article
Acute Respiratory Distress Syndrome: Bench‐to‐Bedside Approaches to Improve Drug Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 484, doi. 10.1002/cpt.1034
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Treosulfan in Patients With Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 575, doi. 10.1002/cpt.988
- By:
- Publication type:
- Article
Overview of the European Medicines Agency's Development of Product‐Specific Bioequivalence Guidelines.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 539, doi. 10.1002/cpt.957
- By:
- Publication type:
- Article
Gaining Mechanistic Insight Into Coproporphyrin I as Endogenous Biomarker for OATP1B‐Mediated Drug–Drug Interactions Using Population Pharmacokinetic Modeling and Simulation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 564, doi. 10.1002/cpt.983
- By:
- Publication type:
- Article
Pharmacologic Targeting of Red Blood Cells to Improve Tissue Oxygenation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 553, doi. 10.1002/cpt.979
- By:
- Publication type:
- Article
A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 546, doi. 10.1002/cpt.974
- By:
- Publication type:
- Article
Food Effect on Rosuvastatin Disposition and Low‐Density Lipoprotein Cholesterol.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 525, doi. 10.1002/cpt.973
- By:
- Publication type:
- Article
Protein Abundance of Clinically Relevant Drug‐Metabolizing Enzymes in the Human Liver and Intestine: A Comparative Analysis in Paired Tissue Specimens.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 515, doi. 10.1002/cpt.967
- By:
- Publication type:
- Article
Population Pharmacokinetics of Polymyxin B.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 534, doi. 10.1002/cpt.981
- By:
- Publication type:
- Article
Model‐Based Assessments of CYP‐Mediated Drug–Drug Interaction Risk of Alectinib: Physiologically Based Pharmacokinetic Modeling Supported Clinical Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 505, doi. 10.1002/cpt.956
- By:
- Publication type:
- Article
Clopidogrel but Not Prasugrel Significantly Inhibits the CYP2C8‐Mediated Metabolism of Montelukast in Humans.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 495, doi. 10.1002/cpt.947
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 401, doi. 10.1002/cpt.844
- Publication type:
- Article